Using a vaccine to boost the response of engineered T cells

FHS
July 5, 2023
6:30 pm

Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn’t worked as well for solid tumors.

bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions – Biotech Investments

bonyf NV / Key word(s): Regulatory Admission/Regulatory Approval bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions 09-Dec-2024 / 15:42 CET/CEST bonyf

December 10, 2024

Opinion | Don’t Neglect Tobacco Use in People Experiencing Homelessness

Vijayaraghavan is an associate professor of medicine and a smoking cessation researcher. The Biden administration is considering a policy to eliminate menthol-flavored tobacco and invest

December 5, 2023

AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2023 – Biotech Investments

AEVIS VICTORIA SA / Key word(s): 9 Month figures 03-Nov-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

November 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.